
浏览全部资源
扫码关注微信
纸质出版:2015
移动端阅览
刘晓丽,马阳,梁源,喻杨,梁云华,王红.慢病毒介导shRNA沉默E2-2基因促进内皮前体细胞增殖[J].陆军军医大学学报(原第三军医大学学报),2015,37(22):2261-2266.
Liu Xiaoli,Ma Yang,Liang Yuan,Yu Yang,Liang Yunhua,Wang Hong.Effect of lentivirus-mediated E2-2 gene silencing on proliferation in endothelial progenitor cells[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(22):2261-2266.
刘晓丽,马阳,梁源,喻杨,梁云华,王红.慢病毒介导shRNA沉默E2-2基因促进内皮前体细胞增殖[J].陆军军医大学学报(原第三军医大学学报),2015,37(22):2261-2266. DOI:
Liu Xiaoli,Ma Yang,Liang Yuan,Yu Yang,Liang Yunhua,Wang Hong.Effect of lentivirus-mediated E2-2 gene silencing on proliferation in endothelial progenitor cells[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(22):2261-2266. DOI:
目的 构建小鼠转录因子基因E2-2 RNA干扰(RNA interference
RNAi)慢病毒载体
并观测其沉默E2-2基因对内皮前体细胞(endothelial progenitor cells
EPCs)增殖的影响。 方法 SPF级昆明小鼠20只,雌雄不拘,4周龄,体质量18~20 g。分离、培养小鼠骨髓EPCs,并予以鉴定。针对E2-2基因mRNA序列,筛选3个siRNA干扰靶点并予以合成;将合成的siRNA导入EPCs,用RT-PCR法检测其对靶基因的抑制效果,以确定最佳siRNA。设计并合成针对最佳siRNA靶序列的shRNA,连入FT203-PLVX载体,构建慢病毒载体FT203-PLVX/E2-2shRNA,并予以测序鉴定。测序正确者经293细胞包装,形成具高效感染力的FT203-PLVX/E2-2shRNA慢病毒。将该重组慢病毒感染EPCs,倒置显微镜观测被感染细胞的绿色荧光蛋白(GFP)的表达变化、CCK-8法检测被感染细胞的增殖情况;在mRNA和蛋白水平分别检测并定量分析被感染细胞的E2-2及核抗原PCNA基因及其编码蛋白的表达变化。 结果 小鼠骨髓EPCs得以分离、培养与鉴定。筛检到E2-2基因的最佳干扰靶序列为CGTCAGCTA-GTGTTTCTAA;测序证实,成功构建FT203-PLVX/E2-2 shRNA慢病毒载体。荧光观察显示,被慢病毒感染的EPCs明显表达GFP。CCK-8检测表明,与对照细胞比较,沉默E2-2的EPCs的增殖加快,48 h开始变得更为明显(P0.01);mRNA和蛋白水平检测及定量分析结果显示,E2-2 shRNA慢病毒能有效沉默EPCs的E2-2,并上调其核抗原PCNA基因及其编码蛋白的表达。 结论 小鼠骨髓EPCs得以分离、培养与鉴定;成功构建E2-2基因RNAi慢病毒载体,该载体能有效沉默EPCs的E2-2基因,促使EPCs的增殖并上调其核抗原PCNA的表达。
Objective To construct RNA interference (RNAi) lentiviral vector targeting murine transcription factor E2-2 gene and investigate its effect on the growth and proliferation of endothelial progenitor cells (EPCs). Methods Murine EPCs were isolated from bone marrow
cultured and identified. Three potential RNAi sites were screened based on the mRNA sequence of E2-2 gene and synthesized. The 3 synthesized siRNAs were transferred into the EPCs
and reverse transcription-polymerase chain reaction (RT-PCR) was used to analyze the inhibitory effect of the target gene so as to identify the optimal siRNA sequence. Then the short-hairpin RNA (shRNA) oligonucleotide targeting the optimal siRNA sequence was designed
synthesized and inserted into FT203-PLVX plasmid to construct FT203-PLVX/E2-2shRNA lentiviral vector. After identifying by sequencing
FT203-PLVX/E2-2shRNA plasmid was transferred into 293 cells to produce lentiviral particles. The EPCs were transfected with the lentiviral particles
and the expression of green fluorescent protein (GFP) in the transfected cells was observed with an inverted microscope. Cell count kit-8 (CCK-8) was used to test the growth and proliferation of the transfected cells. The expression of E2-2
proliferating cell nuclear antigen (PCNA) gene and its encoding protein in the transfected cells were quantitatively detected by RT-PCR and Western blotting. Results Murine EPCs were isolated from the bone marrow
cultured and identified. The optimal siRNA sequence CGTCAGCTAGTGTTTCTAA was confirmed. Sequencing results showed that lentiviral vector FT203-PLVX/E2-2shRNA was constructed successfully. The transfected cells significantly expressed GFP. The CCK-8 results revealed that the growth and proliferation of EPCs were faster after E2-2 gene silencing
especially from 48 h after transfection (P0.01). The results of RT-PCR
Western blotting and quantitative analysis showed that the lentiviral vector FT203-PLVX/E2-2shRNA effectively silenced E2-2 gene and up-regulated the expression of PCNA in the EPCs. Conclusion Murine EPCs are isolated from bone marrow
cultured and identified. The lentiviral vector targeting E2-2 gene can effectively silence E2-2 gene
up-regulate PCNA expression
and promote the growth and proliferation of the EPCs.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621